Australia's most trusted source of pharma news
Sunday, 16 December 2018
News Headlines
Contact Pharma in Focus
If you would like to know more about Pharma in Focus then write, email or phone us.
| Postal Address: | Suite 202 117 Old Pittwater Road Brookvale NSW 2100 |
| Advertising: | +61 2 9938 4381 |
| Editorial: | +61 2 9939 0981 |
| Subscriptions & Access: | +61 2 9939 1881 |
| Fax: | +61 2 9938 5681 | Email: | contact@pharmainfocus.com.au |
If you would like specific information then please fill in the form below and send it to us.
Pipeline Monitor
Roche's lung cancer win
Tecentriq, Avastin combo approved under priority review.
Tecentriq, Avastin combo approved under priority review.
Perspective
Embrace your inner millennial
Younger workers provide valuable insights on balance.
Younger workers provide valuable insights on balance.
Approvals Action
GP adds to GORD options
Generic Partners registers new PPI brands.
Generic Partners registers new PPI brands.